Search Results - Labrenz, Jannik

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease by Heitmann, Jonas S. (Author) , Schlenk, Richard Friedrich (Author) , Dörfel, Daniela (Author) , Kayser, Sabine (Author) , Döhner, Konstanze (Author) , Heuser, Michael (Author) , Thol, Felicitas (Author) , Kapp-Schwoerer, Silke (Author) , Labrenz, Jannik (Author) , Edelmann, Dominic (Author) , Märklin, Melanie (Author) , Vogel, Wichard (Author) , Bethge, Wolfgang (Author) , Walz, Juliane S. (Author) , Große-Hovest, Ludger (Author) , Steiner, Martin (Author) , Jung, Gundram (Author) , Salih, Helmut R. (Author) ,

• Verlag, kostenfrei, Volltext
• Verlag, lizenzpflichtig, Volltext